News for people and friends
Tofersen, a new gene-targeted drug for ALS, is now available in China, offering hope to patients battling this fatal disease. The first injection was administered at Peking University Third Hospital.
Australian scientists have developed PROTEUS, a groundbreaking platform that revolutionizes protein evolution in mammalian cells, paving the way for next-generation medical therapies.
China has approved its first gene therapy for Hemophilia B, offering new hope to patients with this rare blood disorder.